CN1055090C - 结晶性头孢噻夫游离酸 - Google Patents

结晶性头孢噻夫游离酸 Download PDF

Info

Publication number
CN1055090C
CN1055090C CN94191448A CN94191448A CN1055090C CN 1055090 C CN1055090 C CN 1055090C CN 94191448 A CN94191448 A CN 94191448A CN 94191448 A CN94191448 A CN 94191448A CN 1055090 C CN1055090 C CN 1055090C
Authority
CN
China
Prior art keywords
crystalline
ceftiofur
free acid
compound
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN94191448A
Other languages
English (en)
Chinese (zh)
Other versions
CN1119016A (zh
Inventor
M·J·杜恩
M·S·伯格伦
G·E·哈迪
K·P·舍法尔德
R·S·朝
J·L·哈温斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pahpu LLC
Pharmacia and Upjohn Co LLC
Zoetis Services LLC
Original Assignee
Famasia Yup John Usa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Famasia Yup John Usa filed Critical Famasia Yup John Usa
Publication of CN1119016A publication Critical patent/CN1119016A/zh
Application granted granted Critical
Publication of CN1055090C publication Critical patent/CN1055090C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CN94191448A 1993-03-12 1994-03-07 结晶性头孢噻夫游离酸 Expired - Lifetime CN1055090C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3329193A 1993-03-12 1993-03-12
US08/033,291 1993-03-12

Publications (2)

Publication Number Publication Date
CN1119016A CN1119016A (zh) 1996-03-20
CN1055090C true CN1055090C (zh) 2000-08-02

Family

ID=21869579

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94191448A Expired - Lifetime CN1055090C (zh) 1993-03-12 1994-03-07 结晶性头孢噻夫游离酸

Country Status (31)

Country Link
US (1) US5721359A (2)
EP (1) EP0690864B1 (2)
JP (1) JP3852946B2 (2)
KR (1) KR100296810B1 (2)
CN (1) CN1055090C (2)
AT (1) ATE202109T1 (2)
AU (1) AU694419B2 (2)
BR (1) BR1101034A (2)
CA (1) CA2155322C (2)
CZ (1) CZ289332B6 (2)
DE (2) DE69427469T2 (2)
DK (1) DK0690864T3 (2)
ES (1) ES2157254T3 (2)
FI (1) FI120307B (2)
FR (1) FR05C0045I2 (2)
GR (1) GR3036514T3 (2)
HU (1) HU222244B1 (2)
IL (1) IL108910A (2)
LU (1) LU91206I2 (2)
LV (1) LV12889B (2)
NL (1) NL300208I2 (2)
NO (2) NO313199B1 (2)
NZ (1) NZ263002A (2)
PL (1) PL184611B1 (2)
PT (1) PT690864E (2)
RU (1) RU2136685C1 (2)
SI (1) SI0690864T1 (2)
SK (1) SK283674B6 (2)
TW (1) TW267170B (2)
WO (1) WO1994020505A1 (2)
ZA (1) ZA941586B (2)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736151A (en) * 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
US6074657A (en) * 1997-03-20 2000-06-13 Pharmacia & Upjohn Company Administration of an injectable antibiotic in the ear of an animal
WO2002022107A2 (en) * 2000-09-12 2002-03-21 Pharmacia & Upjohn Company Pharmaceutical composition having modified carrier
US7829100B2 (en) * 2000-09-12 2010-11-09 Teagarden Dirk L Pharmaceutical composition having modified carrier
KR100423895B1 (ko) * 2001-02-19 2004-03-24 주식회사 엘지생명과학 셉티오퍼 하이드로클로라이드의 현탁제 조성물
MXPA04000294A (es) * 2001-07-10 2004-05-04 Pharmacia & Upjhon Company Tiacin oxazolidinonas cristalinas.
GEP20063777B (en) 2001-08-15 2006-03-27 Upjohn Co Crystals Including Malic Acid Salt of N-[2-(Diethylamino) Ethyl]-5-[(5-Fluoro-2-Oxo-3h-Indole-3-Ylidene) Methyl]-2, 4-Dimethyl-1h-Pyrrole-3-Carboxamide, Processes for Its Preparation and Compositions Thereof
US20030181398A1 (en) † 2002-03-21 2003-09-25 Brown Scott A. Method of administering an injectable antibiotic to an animal
US20040022815A1 (en) * 2002-08-05 2004-02-05 Orchid Health Care Novel pharmaceutical composition of ceftiofur
KR20040015622A (ko) * 2002-08-13 2004-02-19 대한뉴팜(주) 세프티오푸르나트륨을 활성성분으로 함유하는 현탁주사액조성물
US20040115822A1 (en) * 2002-09-12 2004-06-17 Schapaugh Randal Lee Methods of measuring the dissolution rate of an analyte in a non-aqueous liquid composition
US7659061B2 (en) * 2002-11-19 2010-02-09 Pharmacia & Upjohn Company Pharmaceutical compositions having a modified vehicle
US20040115837A1 (en) * 2002-11-27 2004-06-17 Schapaugh Randal Lee Methods of measuring the dissolution rate of an analyte in a non-aqueous liquid composition
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
BRPI0408716B1 (pt) * 2003-03-27 2017-08-29 Basilea Pharmaceutica Ag. Cefalosporin in crystalline form, process for its preparation and its uses, and preparation of cephalosporin
CZ23088U1 (cs) 2004-03-25 2011-12-19 Astellas Pharma Inc. Kompozice pevného farmaceutického prípravku solifenacinu nebo jeho soli
US7815939B2 (en) 2005-07-20 2010-10-19 Astellas Pharma Inc. Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms
US8470809B2 (en) * 2005-10-12 2013-06-25 Orchid Chemicals & Pharmaceuticals Limited Crystalline sodium salt of cephalosporin antibiotic
WO2007042917A1 (en) * 2005-10-12 2007-04-19 Orchid Chemicals And Pharmaceuticals Limited Crystalline sodium salt of cephalosporin antibiotic
SA08290520B1 (ar) 2007-08-22 2012-02-22 استرازينيكا ايه بي مشتقات سيكلو بروبيل أميد وتركيبات صيدلية تحتوي عليها لعلاج حالة مرضية سببها مستقبلات هيستامين h3
US9943614B2 (en) 2008-06-17 2018-04-17 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
US8431562B2 (en) * 2008-08-22 2013-04-30 Orchid Chemicals & Pharmaceuticals Limited Crystalline sodium salt of cephalosporin antibiotic
EP2367572B1 (en) * 2008-11-19 2018-08-29 Merial, Inc. Formulations comprising ceftiofur and benzyl alcohol
US20110288142A1 (en) * 2009-01-30 2011-11-24 Chen Pingyun Y CRYSTALLINE N--5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
RU2012139082A (ru) * 2010-02-18 2014-03-27 Астразенека Аб Способы получения производных циклопропиламида и связанных с ними промежуточных соединений
JP5746718B2 (ja) * 2010-02-18 2015-07-08 アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａ Ａｋｔｉｅｂｏｌａｇ シクロプロピルアミド誘導体からなる固体形態
WO2012150520A1 (en) * 2011-05-02 2012-11-08 Pfizer Inc. Novel cephalosporins useful as antibacterial agents
KR102220710B1 (ko) 2011-07-20 2021-03-02 브라이엄 영 유니버시티 소수성 세라게닌 화합물 및 이를 포함하는 기구
US9694019B2 (en) 2011-09-13 2017-07-04 Brigham Young University Compositions and methods for treating bone diseases and broken bones
CN104080459B (zh) 2011-09-13 2018-07-03 布莱阿姆青年大学 用于治疗骨疾病和断骨的组合物
US9603859B2 (en) 2011-09-13 2017-03-28 Brigham Young University Methods and products for increasing the rate of healing of tissue wounds
CN104080458B (zh) 2011-09-13 2020-06-02 布莱阿姆青年大学 用于组织创伤的愈合的产品
CN104379120A (zh) 2011-12-21 2015-02-25 布莱阿姆青年大学 口腔护理组合物
CN102584855B (zh) * 2012-02-16 2014-06-25 青岛科技大学 一种改进的头孢噻呋的制备方法
US9533063B1 (en) 2012-03-01 2017-01-03 Brigham Young University Aerosols incorporating ceragenin compounds and methods of use thereof
WO2013165574A2 (en) 2012-05-02 2013-11-07 Brigham Young University Ceragenin particulate materials and methods for making same
BR112015008804A2 (pt) 2012-10-17 2017-07-04 Univ Brigham Young tratamento e prevenção de mastite
US9518004B2 (en) * 2012-12-03 2016-12-13 Kaneka Corporation Reduced coenzyme Q10 derivative and method for production thereof
US9943529B2 (en) 2013-01-07 2018-04-17 Brigham Young University Methods for reducing cellular proliferation and treating certain diseases
US11524015B2 (en) 2013-03-15 2022-12-13 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
WO2014151411A1 (en) 2013-03-15 2014-09-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US10568893B2 (en) 2013-03-15 2020-02-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
RU2546675C2 (ru) * 2013-04-11 2015-04-10 Федеральное казённое предприятие "Государственный научно-исследовательский институт химических продуктов" (ФКП "ГосНИИХП") Способ определения степени кристалличности составов на основе дифениламина
US9387215B2 (en) 2013-04-22 2016-07-12 Brigham Young University Animal feed including cationic cholesterol additive and related methods
KR20230159631A (ko) * 2013-09-05 2023-11-21 미쓰비시 타나베 파마 코퍼레이션 신규한 결정성 아릴알킬아민 화합물 및 그의 제조 방법
US11690855B2 (en) 2013-10-17 2023-07-04 Brigham Young University Methods for treating lung infections and inflammation
US20150203527A1 (en) 2014-01-23 2015-07-23 Brigham Young University Cationic steroidal antimicrobials
CA2844321C (en) 2014-02-27 2021-03-16 Brigham Young University Cationic steroidal antimicrobial compounds
US10220045B2 (en) 2014-03-13 2019-03-05 Brigham Young University Compositions and methods for forming stabilized compositions with reduced CSA agglomeration
US9867836B2 (en) 2014-03-13 2018-01-16 Brigham Young University Lavage and/or infusion using CSA compounds for increasing fertility in a mammal
US9931350B2 (en) 2014-03-14 2018-04-03 Brigham Young University Anti-infective and osteogenic compositions and methods of use
US9686966B2 (en) 2014-04-30 2017-06-27 Brigham Young University Methods and apparatus for cleaning or disinfecting a water delivery system
US10441595B2 (en) 2014-06-26 2019-10-15 Brigham Young University Methods for treating fungal infections
US10238665B2 (en) 2014-06-26 2019-03-26 Brigham Young University Methods for treating fungal infections
US10227376B2 (en) 2014-08-22 2019-03-12 Brigham Young University Radiolabeled cationic steroid antimicrobials and diagnostic methods
US10155788B2 (en) 2014-10-07 2018-12-18 Brigham Young University Cationic steroidal antimicrobial prodrug compositions and uses thereof
CN111825717A (zh) 2014-10-21 2020-10-27 阿瑞雅德制药公司 5-氯-n4-[2-(二甲基磷酰基)苯基]-n2-{2-甲氧基-4-[4-(4-甲基哌嗪-1-基)哌啶-1-基]苯基}嘧啶-2,4-二胺的晶形
WO2016172553A1 (en) 2015-04-22 2016-10-27 Savage Paul B Methods for the synthesis of ceragenins
US10370403B2 (en) 2015-04-22 2019-08-06 Brigham Young University Methods for the synthesis of ceragenins
KR101753842B1 (ko) * 2015-05-12 2017-07-04 한국화학연구원 불화퀴놀론계 항생제를 담지한 서방형 제제 및 이의 제조방법
US9434759B1 (en) 2015-05-18 2016-09-06 Brigham Young University Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds
CN106543203B (zh) * 2015-09-18 2019-07-02 瑞普（天津）生物药业有限公司 一种长效头孢噻呋自由酸晶体的制备方法
EP3778567A1 (en) * 2016-01-22 2021-02-17 Sandoz Ag Crystalline eravacycline bis-hydrochloride
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
KR101898282B1 (ko) * 2016-05-24 2018-09-13 주식회사 고려비엔피 항생제의 서방형 수의학적 조성물 및 이의 제조방법
MX389964B (es) * 2016-07-07 2025-03-19 Cyclerion Therapeutics Inc Formas sólidas de un estimulador de guanilato ciclasa soluble (sgc).
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity
US11186556B1 (en) * 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof
UA119735C2 (uk) 2018-12-20 2019-07-25 Анатолій Семенович Редер Фармацевтична сполука, спосіб її отримання та застосування як лікарського засобу
AU2020274083B9 (en) 2019-05-13 2025-05-01 D.E. Shaw Research, Llc FGFR inhibitors and methods of use thereof
US12186328B2 (en) 2019-05-23 2025-01-07 Brigham Young University Use of CSA compounds to stimulate stem cells and hair growth
TW202233625A (zh) * 2020-11-18 2022-09-01 美商傳達治療有限公司 Ｆｇｆｒ抑制劑及其製造及使用方法
CN117229296A (zh) * 2023-09-14 2023-12-15 广东温氏大华农生物科技有限公司 一种头孢噻呋酸晶体及其制备方法与应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987006231A1 (en) * 1986-04-12 1987-10-22 Beecham Group P.L.C. beta-LACTAM ANTIBIOTICS
EP0273156A2 (en) * 1986-12-23 1988-07-06 Giovanni Bonfanti Method for producing pure crystalline products

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1207933B (de) * 1962-12-26 1965-12-30 American Home Prod Verfahren zur Herstellung von kristallwasser-freiem D-alpha-Aminobenzylpenicillin
US3489751A (en) * 1967-09-05 1970-01-13 Bristol Myers Co 7-amino-cephalosporanic and decephalosporanic acid derivatives
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
GB1532682A (en) * 1976-04-27 1978-11-22 Bristol Myers Co Process for the preparation of cephadroxil
FR2479229B1 (fr) * 1980-03-26 1986-01-17 Clin Midy Nouveaux derives des cephalosporines, leur procede de preparation et les medicaments utilisables comme antibiotiques qui contiennent lesdits derives
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US4400503A (en) * 1981-10-30 1983-08-23 Eli Lilly And Company Purification of syn-7-[[(2-amino-4-thiazolyl)(methoxyimino) acetyl]amino]-3-methyl-3-cephem-4-carboxylic acid
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
HU196714B (en) * 1984-10-04 1989-01-30 Monsanto Co Process for producing non-aqueous composition comprising somatotropin
US4902683A (en) * 1984-10-25 1990-02-20 The Upjohn Company Crystalline cephalosporin hydrohalide salts
IT1181672B (it) * 1984-10-25 1987-09-30 Upjohn Co Cefalosporina alogenidrato cristallino
FR2585705B1 (fr) * 1985-08-05 1989-01-13 Bristol Myers Co Sels de cephalosporine et compositions injectables
DE3650526T2 (de) * 1985-08-12 1996-10-31 Upjohn Co Umwandlung des cephalosporin-hydrohalid-salzes zu einem alkalimetallsalz
ES2032543T3 (es) * 1987-02-02 1993-02-16 Eli Lilly And Company Procedimiento mejorado de preparacion de un antibiotico.
AU611461B2 (en) * 1987-07-29 1991-06-13 Pharmacia & Upjohn Company Controlled release of antibiotic salts from an implant
AU617377B2 (en) * 1987-11-10 1991-11-28 Pharmacia & Upjohn Company Cephalosporin antibiotics
US4877782A (en) * 1988-02-16 1989-10-31 The Upjohn Company Zinc ceftiofur complexes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987006231A1 (en) * 1986-04-12 1987-10-22 Beecham Group P.L.C. beta-LACTAM ANTIBIOTICS
EP0273156A2 (en) * 1986-12-23 1988-07-06 Giovanni Bonfanti Method for producing pure crystalline products

Also Published As

Publication number Publication date
GR3036514T3 (en) 2001-12-31
CZ9502290A3 (cs) 2001-08-15
FI120307B (fi) 2009-09-15
DE69427469T2 (de) 2001-10-31
AU694419B2 (en) 1998-07-23
IL108910A (en) 1999-10-28
PL184611B1 (pl) 2002-11-29
EP0690864B1 (en) 2001-06-13
JP3852946B2 (ja) 2006-12-06
US5721359A (en) 1998-02-24
FI954250A0 (fi) 1995-09-11
TW267170B (2) 1996-01-01
NZ263002A (en) 1996-12-20
SI0690864T1 (en) 2001-10-31
ES2157254T3 (es) 2001-08-16
BR1101034A (pt) 2002-04-30
NL300208I2 (nl) 2006-05-01
DK0690864T3 (da) 2001-09-17
CA2155322A1 (en) 1994-09-15
RU2136685C1 (ru) 1999-09-10
AU6351094A (en) 1994-09-26
HUT73781A (en) 1996-09-30
SK283674B6 (sk) 2003-11-04
SK111495A3 (en) 1995-12-06
CN1119016A (zh) 1996-03-20
ZA941586B (en) 1995-09-07
ATE202109T1 (de) 2001-06-15
HU9501960D0 (en) 1995-09-28
LV12889B (lv) 2002-12-20
PL310556A1 (en) 1995-12-27
KR100296810B1 (ko) 2001-10-24
DE69427469D1 (en) 2001-07-19
NO953564D0 (no) 1995-09-11
NO2005025I2 (no) 2010-11-22
PT690864E (pt) 2001-11-30
NL300208I1 (nl) 2006-02-01
CZ289332B6 (cs) 2002-01-16
IL108910A0 (en) 1994-06-24
EP0690864A1 (en) 1996-01-10
DE122005000055I2 (de) 2008-06-05
FR05C0045I1 (2) 2006-01-06
FI954250L (fi) 1995-09-11
HU222244B1 (hu) 2003-05-28
DE122005000055I1 (de) 2006-02-23
JPH08507519A (ja) 1996-08-13
LU91206I2 (fr) 2006-05-30
CA2155322C (en) 2000-02-29
NO313199B1 (no) 2002-08-26
FR05C0045I2 (2) 2007-08-03
NO953564L (no) 1995-11-07
NO2005025I1 (no) 2005-12-05
WO1994020505A1 (en) 1994-09-15

Similar Documents

Publication Publication Date Title
CN1055090C (zh) 结晶性头孢噻夫游离酸
CN1151845C (zh) 含有晶体学稳定的无定形头孢茵素的组合物及其制备方法
CN1089948A (zh) 三唑基硫甲基硫代头孢菌素氢氯化物，它的结晶水合物及其制备
HK1054387A1 (zh) 稠合咪唑并吡啶衍生物的新生产方法和新晶体形式
CN1032793A (zh) 结晶态的β-内酰胺水合物
CN1705483A (zh) 延长释放的药物组合物
WO2004104010A1 (en) Crystalline form of cefdinir
JPS6145626B2 (2)
JP2007529521A (ja) セフジニルの三半水和物、無水物および水和物形態
CN1902207A (zh) 高纯度3－(2－取代乙烯基)头孢菌素的制备方法
EP0329286A1 (en) Zinc ceftiofur complexes
CN1107067C (zh) 碳代青霉烯化合物、其用途及其中间体化合物
CN1024754C (zh) 抗菌冻干制剂
CN102471350B (zh) 制造头孢喹肟颗粒的方法
CN1092663C (zh) 新型头孢菌素衍生物及其制备方法
CN1216246A (zh) 抗微生物组合物
JPH01199977A (ja) セファロスポリン誘導体の結晶、その製造法およびそれらを有効成分とする医薬組成物
KR850001353B1 (ko) 페니실란산 1,1-디옥사이드의 수 난용성 염의 제조방법
HK1035148B (en) Crystallographically stable amorphous cephalosporin compositions and process for producing the same

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent of invention or patent application
CB02 Change of applicant information

Applicant after: PHARMACIA & UPJOHN Co.

Applicant before: The Upjohn Co.

COR Change of bibliographic data

Free format text: CORRECT: APPLICANT; FROM: UPJOHN COMPANY TO: PHARMACIA + UPJOHN CO.

C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: PAH

Free format text: FORMER OWNER: UPJOHN CO.

Effective date: 20130619

C41 Transfer of patent application or patent right or utility model
C56 Change in the name or address of the patentee

Owner name: ZOETIS PU CO., LTD.

Free format text: FORMER NAME: PAH

CP01 Change in the name or title of a patent holder

Address after: American New Jersey

Patentee after: Zoetis Services LLC

Address before: American New Jersey

Patentee before: PAHPU LLC

Address after: Michigan

Patentee after: PHARMACIA & UPJOHN CO.,LLC

Address before: Michigan

Patentee before: PHARMACIA & UPJOHN Co.

TR01 Transfer of patent right

Effective date of registration: 20130619

Address after: American New Jersey

Patentee after: PAHPU LLC

Address before: Michigan

Patentee before: PHARMACIA & UPJOHN CO.,LLC

C17 Cessation of patent right
CX01 Expiry of patent term

Expiration termination date: 20140307

Granted publication date: 20000802